Platform  Description  Value added  Future
 opportunities
  Matrix tablets
  • Hydrophilic
  • Insoluble
 Controlled release tablets-
wet granulation or direct compression
  • Adjustment of dissolution profile

  • Obtaining bioequivalence

  • Fewer adverse reactions
 Sustained release preparations, fewer dosings, fewer adverse reactions
  Susatined
  release
  tablets		 Coating of tablets
  • Adjustment of dissolution profile

  • Obtaining bioequivalence

  • Fewer adverse reactions
 None - risk of dose dumping too high
  Sustained
  release
  minitablets		 Standard tabletting technology, coating and capsule filling
  • Adjustment of dissolution profile

  • Obtaining bioequivalence

  • Fewer adverse reactions

  • Patent opportunity if pellets are covered
 Sustained release preparations where pellets are patented
  Coloured
  immediate
  release
  tablets		 Uncoated tablets with coloured granules
  • Pleasant look when broken compared to white tablets coated with coloured film
  • No coating process needed
 Uncoated tablets
  Chewable
  tablets		 Tablet intended for chewing
- taste masking of unpleasant APIs needed
  • Popular among children
 Other products relevant for children
TECHNOLOGY PLATFORMS 2/3